Results 251 to 260 of about 52,905 (310)

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 5, Page 766-780, May 2026.
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu   +4 more
wiley   +1 more source

Characterization of lipoprotein composition and function in pediatric psoriasis reveals a more atherogenic profile [PDF]

open access: yes, 2015
Admani, S   +5 more
core  

Body Weight-Related Differences in Adipokines and Inflammatory Markers Among Women with Systemic Lupus Erythematosus. [PDF]

open access: yesJ Inflamm Res
Carvalho LM   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy